THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS
সংরক্ষণ করুন:
CAVANAGH, R., ET AL., THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 21, no. 2 (1989), p. 217-220.
Ref.
11225
অবস্থান:
SIIS R.829 Depósito (106/107)
Palabras clave:
Drogodependencias, Enfermedades mentales, Fármacos, Trastornos de atención
Drogodependencias, Enfermedades mentales, Fármacos, Trastornos de atención
অনুরূপ উপাদানগুলি: THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS
- DIAGNOSING ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND LEARNING DISABILITIES WITH CHEMICALLY DEPENDENT ADOLESCENTS
- RECOGNIZING AND TREATING ATTENTION DEFICIT DISORDERS IN CHEMICALLY DEPENDENT ADOLESCENTES
- BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- BROMOCRIPTINE AS INITIAL THERAPY IN ELDERLY PARKINSONIAN PATIENTS
- COMPARISON OF CLONIDINE RESPONSE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH AND WITHOUT COMORBID TIC DISORDERS
- AN OPEN TRIAL OF GUANFACINE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER